Compare KSCP & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KSCP | COCH |
|---|---|---|
| Founded | 2013 | 1995 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Telecommunications Equipment | Blank Checks |
| Sector | Telecommunications | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.1M | 59.7M |
| IPO Year | 2022 | N/A |
| Metric | KSCP | COCH |
|---|---|---|
| Price | $3.58 | $0.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.67 | $9.50 |
| AVG Volume (30 Days) | ★ 576.8K | 334.4K |
| Earning Date | 05-13-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.54 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,335,000.00 | N/A |
| Revenue This Year | $9.63 | N/A |
| Revenue Next Year | $31.03 | $25.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.91 | N/A |
| 52 Week Low | $2.46 | $0.36 |
| 52 Week High | $10.13 | $1.91 |
| Indicator | KSCP | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 41.32 | 41.99 |
| Support Level | $2.92 | $0.36 |
| Resistance Level | $4.50 | $0.90 |
| Average True Range (ATR) | 0.48 | 0.09 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 6.09 | 7.22 |
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.